CamposAC, MoreiraFA, GomesFV, et al.Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. Philos Trans R Soc Lond B Biol Sci, 2012; 367(1607):3364–3378.
2.
Fernández-RuizJ, SagredoO, PazosMR, et al.Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?. Br J Clin Pharmacol, 2013; 75(2):323–333.
3.
FeldmeyerL, HeidemeyerK, YawalkarN.Acute generalized exanthematous pustulosis: pathogenesis, genetic background, clinical variants and therapy. Int J Mol Sci, 2016; 17(8).
4.
LuLK, HighWA. Acute generalized exanthematous pustulosis caused by illicit street drugs?. Arch Dermatol, 2007; 143(3):430–431.
5.
DhadwalG, KirchhofMG. The risks and benefits of cannabis in the dermatology clinic. J Cutan Med Surg, 2018; 22(2):194–199.
